Delivery Order SPE2DR25D3504-SPE2DR26F7CX3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,368.50 to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (18 count) on January 29, 2026, with completion expected by January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.59 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office based in Conshohocken, Pennsylvania. The delivery location is also Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,835.24 to AmerisourceBergen Drug Corp for Yuvafem 10 MCG vaginal inserts (18 count) on October 17, 2025, with completion scheduled for October 20, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.01 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.80 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count) on December 3, 2025, with an ultimate completion date of December 4, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside arrangement. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child contract...
- The Defense Logistics Agency has awarded a delivery order valued at $1,822.14 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count package). This firm fixed-price, non-competitive delivery order was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,086.86 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on December 17, 2025, with completion scheduled for December 18, 2025. This competitively awarded, firm fixed-price delivery order was performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $1,170.77 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-pack) with an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered from the contractor's corporate office location in...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7CX3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,771.21 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price, competitively awarded contract (no set-aside used) will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, significant Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 2031 that serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, regularly fulfills medical supply requirements for the Defense Health Agency and other government healthcare systems through this IDC structure. The company maintains extensive experience delivering prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. This particular delivery order for hormone therapy medication demonstrates the contractor's ongoing capability to efficiently meet federal pharmaceutical procurement needs through the established prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 2/1/26 |